Timothy R. Fricke

Timothy R. Fricke

Auto-generated profile, based on publicly available information

Timothy R. Fricke

School of Optometry and Vision Science, UNSW, Sydney, NSW, Australia

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2018 in Ophthalmology
Verified
Journal Article
Open access
TFTimothy R. Fricke
Timothy R. Fricke
NTNina Tahhan
Nina Tahhan
Serge ResnikoffSerge Resnikoff
Serge Resnikoff
EPEric Papas
Eric Papas
ABAnthea Burnett
Anthea Burnett
KNKovin S. Naidoo
Kovin S. Naidoo
Presbyopia prevalence and spectacle-correction coverage were estimated by systematic review and meta-analysis of epidemiologic evidence, then modeled to expand to country, region, and global estimates. Understanding presbyopia epidemiologic factors and correction coverage is critical to overcoming the burden of vision impairment (VI) from uncorrected presbyopia. We performed systematic reviews of presbyopia prevalence and spectacle-correction coverage. Accepted presbyopia prevalence data were gathered into 5-year age groups from 0 to 90 years or older and meta-analyzed within World Health Organization global burden of disease regions. We developed a model based on amplitude of accommodation adjusted for myopia rates to match the regionally meta-analyzed presbyopia prevalence. Presbyopia spectacle-correction coverage was analyzed against country-level variables from the year of data collection; variation in correction coverage was described best by a model based on the Human Development Index, Gini coefficient, and health expenditure, with adjustments for age and urbanization. We used the models to estimate presbyopia prevalence and spectacle-correction coverage in each age group in urban and rural areas of every country in the world, and combined with population data to estimate the number of people with near VI. We estimate there were 1.8 billion people (prevalence, 25%; 95% confidence interval [CI], 1.7-2.0 billion [23%-27%]) globally with presbyopia in 2015, 826 million (95% CI, 686-960 million) of whom had near VI because they had no, or inadequate, vision correction. Global unmet need for presbyopia correction in 2015 is estimated to be 45% (95% CI, 41%-49%). People with presbyopia are more likely to have adequate optical correction if they live in an urban area of a more developed country with higher health expenditure and lower inequality. There is a significant burden of VI from uncorrected presbyopia, with the greatest burden in rural areas of low-resource countries.

1 March 2019 in Ophthalmology
Verified
Journal Article
Open access
KNKovin S. Naidoo
Kovin S. Naidoo
TFTimothy R. Fricke
Timothy R. Fricke
KFKevin D. Frick
Kevin D. Frick
MJMonica Jong
Monica Jong
TNThomas J. Naduvilath
Thomas J. Naduvilath
PSPadmaja Sankaridurg
Padmaja Sankaridurg
We estimated the potential global economic productivity loss resulting from vision impairment (VI) and blindness as a result of uncorrected myopia and myopic macular degeneration (MMD) in 2015. Understanding the economic burden of VI associated with myopia is critical to addressing myopia as an increasingly prevalent public health problem. We estimated the number of people with myopia and MMD corresponding to critical visual acuity thresholds. Spectacle correction coverage was analyzed against country-level variables from the year of data collection; variation in spectacle correction was described best by a model based on a human development index, with adjustments for urbanization and age. Spectacle correction and myopia data were combined to estimate the number of people with each level of VI resulting from uncorrected myopia. We then applied disability weights, labor force participation rates, employment rates, and gross domestic product per capita to estimate the potential productivity lost among individuals with each level and type of VI resulting from myopia in 2015 in United States dollars (US$). An estimate of care-associated productivity loss also was included. People with myopia are less likely to have adequate optical correction if they are older and live in a rural area of a less developed country. The global potential productivity loss associated with the burden of VI in 2015 was estimated at US$244 billion (95% confidence interval [CI], US$49 billion-US$697 billion) from uncorrected myopia and US$6 billion (95% CI, US$2 billion-US$17 billion) from MMD. Our estimates suggest that the Southeast Asia, South Asia, and East Asia Global Burden of Disease regions bear the greatest potential burden as a proportion of their economic activity, whereas East Asia bears the greatest potential burden in absolute terms. Even under conservative assumptions, the potential productivity loss associated with VI and blindness resulting from uncorrected myopia is substantially greater than the cost of correcting myopia.

8 December 2008 in Archives of Ophthalmology (1950)
Verified
Journal Article
Open access
PDF file
BHBrien A. Holden
Brien A. Holden
TFTimothy R. Fricke
Timothy R. Fricke
SHS. May Ho
S. May Ho
RWReg Wong
Reg Wong
GSGerhard Schlenther
Gerhard Schlenther
KFKevin D. Frick
Kevin D. Frick
Uncorrected distance refractive error is the most common cause of vision impairment and the second most common cause of blindness in the world.1-4Although presbyopia creates refractive error affecting the near vision of older people,5it is not included in the World Health Organization reported prevalence of uncorrected refractive error.4,6However, the combination of the high prevalence in older adults and the low rates of spectacle access in some communities means that presbyopia has the potential to cause a global burden of vision loss worthy of attention.

26 April 2018 in British Journal of Ophthalmology
Verified
Journal Article
Open access
PDF file
TFTimothy R Fricke
Timothy R Fricke
MJMonica Jong
Monica Jong
KNKovin S Naidoo
Kovin S Naidoo
PSPadmaja Sankaridurg
Padmaja Sankaridurg
TNThomas J Naduvilath
Thomas J Naduvilath
Serge ResnikoffSerge Resnikoff
Serge Resnikoff
Purpose We used systematic review and meta-analysis to identify and assimilate evidence quantifying blindness and visual impairment (VI) associated with myopic macular degeneration (MMD), then derived models to predict global patterns. The models were used to estimate the global prevalence of blindness and VI associated with MMD from 2000 to 2050. Methods The systematic review identified 17 papers with prevalence data for MMD VI fitting our inclusion criteria. Data from six papers with age-specific data were scaled to relative age-dependent risk and meta-analysed at VI and blindness levels. We analysed variance in all MMD VI and blindness data as a proportion of high myopia against variables from the place and year of data collection, with a model based on health expenditure providing the best correlation. We used this model to estimate the prevalence and number of people with MMD VI in each country in each decade. Results We included data from 17 studies comprising 137 514 participants. We estimated 10.0 million people had VI from MMD in 2015 (prevalence 0.13%, 95% CI 5.5 to 23.7 million, 0.07% to 0.34%), 3.3 million of whom were blind (0.04%, 1.8 to 7.8 million, 0.03% to 0.10%). We estimate that by 2050, without changing current interventions, VI from MMD will grow to 55.7 million people (0.57%, 29.0 to 119.7 million, 0.33% to 1.11%), 18.5 million of whom will be blind (0.19%, 9.6 to 39.7 million, 0.11% to 0.37%). Conclusion The burden of MMD blindness and VI will rise significantly without efforts to reduce the development and progression of myopia and improve the management of MMD.

1 September 1997 in Clinical and Experimental Optometry
Verified
Journal Article
Closed access
PDF file
TFTimothy R Fricke
Timothy R Fricke
JSJohn Siderov
John Siderov

1 June 2009 in Optometry and Vision Science
Verified
Journal Article
Closed access
LALauren N. Ayton
Lauren N. Ayton
LALarry Allen Abel
Larry Allen Abel
TFTimothy R. Fricke
Timothy R. Fricke
NMNeville A. McBrien
Neville A. McBrien